<- Go Home

SOL S.p.A.

SOL S.p.A. produces and distributes technical and medical gases for industry and healthcare facilities in Italy and internationally. The company supplies technical gases, equipment, systems, and services for the industrial sectors; and produces and distributes gases, such as oxygen, nitrogen, argon, hydrogen, carbon dioxide, sulphur dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, gaseous helium, liquid helium, gases for electronics, ammonia, combustible gases for industrial use, and liquefied natural gas. It also provides medical gases with AIC and medical devices, training services, electromedical equipment services, hospital hygiene and environmental monitoring, ambulance management, design and development of biobanks, and InfoHealth solutions; and respiratory and infusion therapies, healthcare and social care services, telemedicine and digital services, and healthcare aids. In addition, the company offers CRYOLAB for transfer, storage and handling services of biological samples; DIATHEVA, which focuses on research, development, production, and marketing products, including monoclonal antibodies, recombinant proteins, and molecular kits for hospital research, diagnosis and clinical application, environmental, veterinary, and food; and PERSONAL GENOMICS for preventive and precision medicine. SOL S.p.A. was founded in 1927 and is headquartered in Monza, Italy. SOL S.p.A. operates as a subsidiary of Gas And Technologies World B.V.

Market Cap

EUR 4.8B

Volume

35.7K

Cash and Equivalents

EUR 340.6M

EBITDA

EUR 409.9M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

EUR 445.5M

Profit Margin

24.70%

52 Week High

EUR 64.00

52 Week Low

EUR 44.85

Dividend

0.84%

Price / Book Value

4.26

Price / Earnings

29.01

Price / Tangible Book Value

5.88

Enterprise Value

EUR 5.4B

Enterprise Value / EBITDA

12.28

Operating Income

EUR 269.2M

Return on Equity

15.50%

Return on Assets

7.38

Cash and Short Term Investments

EUR 340.6M

Debt

EUR 800.5M

Equity

EUR 1.2B

Revenue

EUR 1.8B

Unlevered FCF

EUR 49.7M

Sector

Chemicals

Category

N/A

Company Stock Pitches